
Sector: Healthcare
ZA_NTC
Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.
Shares: yahoo_fundamentals_timeseries/NTC.JO
Monetary columns are in M USD, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.
| Date | Period | Status | RevenueM USD | Operating profitM USD | D&AM USD | EBITDAM USD | Net profitM USD | Operating CFM USD | Capex + M&AM USD | AssetsM USD | EquityM USD | ROE (annualized) | Net debtM USD | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | H1 2026 (6M) | OK | 802.2 y/y 17.3% | 106.2 y/y 20.7% | 43.2 y/y 17.0% | 149.4 y/y 19.6% | 53.6 y/y 26.3% | 44.5 | -413.0 | 1721.3 y/y 13.9% | 640.8 y/y 9.0% | 16.9% | 6113.0 | Link |
| 2025-09-30 | H2 2025 (6M) | OK | 771.2 y/y 5.0% | 120.4 y/y 13.8% | 37.8 y/y 1.5% | 158.2 y/y 10.6% | 53.9 y/y 17.8% | 72.7 | -1224.0 | 1691.8 y/y 2.3% | 629.3 y/y -1.2% | 15.8% | 5478.0 | — |
| 2025-03-31 | H1 2025 (6M) | OK | 684.1 y/y 6.6% | 88.0 y/y 13.0% | 36.9 y/y 4.1% | 124.9 y/y 10.2% | 42.4 y/y 17.5% | 62.5 | -406.0 | 1511.2 y/y 2.6% | 588.1 y/y 0.3% | 13.9% | 5634.0 | Link |
| 2024-09-30 | H2 2024 (6M) | OK | 734.2 y/y 14.0% | 105.8 y/y 32.5% | 37.3 y/y 9.9% | 143.1 y/y 25.8% | 45.7 y/y 27.0% | 86.4 | -1025.0 | 1653.3 y/y 12.2% | 636.7 y/y 9.0% | 13.4% | 5306.0 | — |
| 2024-03-31 | H1 2024 (6M) | OK | 641.7 y/y -2.2% | 77.9 y/y 1.3% | 35.5 y/y -1.1% | 113.3 y/y 0.5% | 36.1 y/y -0.9% | 15.6 | -494.0 | 1473.5 y/y -2.3% | 586.6 y/y -6.0% | 12.3% | 5841.0 | Link |
| 2023-09-30 | H2 2023 (6M) | OK | 643.9 y/y — | 79.8 y/y — | 33.9 y/y — | 113.7 y/y — | 36.0 y/y — | 54.0 | -1103.0 | 1474.1 y/y — | 584.3 y/y — | 12.0% | 5028.0 | — |
| 2023-03-31 | H1 2023 (6M) | OK | 655.9 y/y — | 76.9 y/y — | 35.9 y/y — | 112.7 y/y — | 36.4 y/y — | 49.1 | -404.0 | 1508.3 y/y — | 624.2 y/y — | — | 4993.0 | Link |
Quarterly values (ZAR mln)
Year-over-year change
FCF (ZAR mln)
Net debt / cash (ZAR mln)
| year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| cash flow / profit | 1.86x | 1.42x | 1.25x | 1.40x |
| accruals, % of assets | -3.3% | -2.0% | -1.3% | -2.4% |
Value the company creates per year, as a % of market cap
Value created per year: +24.9%
| 1. EBITDA growth (latest quarter YoY, annualised) [EBITDA latest qtr − EBITDA year-ago qtr] × annualisation X (2026-03-31 vs 2025-03-31) = (149 − 125) × 2.07 | 51 |
| 2. Current EV/EBITDA (LTM) (Market cap + Net debt) ÷ EBITDA (LTM) = (1 349 + 6 113) ÷ 310 | 24.1x |
| 3. Target multiple (Current EV/EBITDA + 8) ÷ 2 = (24.1 + 8) ÷ 2 | 16.0x |
| 4. Cash flow (balance method, LTM) Net-debt reduction + dividends + buybacks − equity issuance = -479 + 0 + 0 − 0 | -479 |
| 5. Value created per year (EBITDA growth × Target multiple + Cash flow − Dilution) ÷ Market cap = (51 × 16.0 + -479) ÷ 1 349 | +24.9% |
Amounts in millions of the reporting currency. EBITDA growth is the latest quarter vs the same quarter a year ago, annualised.
Caveats:
| Date | Per share | Details | Status | Source |
|---|---|---|---|---|
| 2026-07-08 | 44 ZAR | Ex-dividend: 44 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2026-01-21 | 49 ZAR | Ex-dividend: 49 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2025-07-09 | 36 ZAR | Ex-dividend: 36 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2025-01-22 | 40 ZAR | Ex-dividend: 40 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2024-07-10 | 30 ZAR | Ex-dividend: 30 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2024-01-24 | 35 ZAR | Ex-dividend: 35 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2023-07-12 | 30 ZAR | Ex-dividend: 30 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2023-01-25 | 30 ZAR | Ex-dividend: 30 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2022-07-06 | 20 ZAR | Ex-dividend: 20 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2022-01-26 | 34 ZAR | Ex-dividend: 34 ZAR per share | Paid | Yahoo Finance (ex-div) |
KASE: status follows wording in the news headline (paid vs intends to pay). Yahoo: amounts are cash dividends per share on ex-dividend dates (UTC calendar date). stockscope.uz (UZ): amounts are per share in UZS by publication date (not necessarily ex-div).
Reporting forms detected in loaded periods: ✓ ✓ ✓ (Balance sheet / Profit or loss (P&L) / Cash flows)
Financial results, valuation multiples (P/E, P/B, EV/EBITDA), profitability and dividend yield of Netcare (NTC) — from primary filings.
Netcare operates private hospitals and emergency medical services in South Africa, along with primary care clinics, mental health facilities, and diagnostic services.
See also: South African Stocks (2026): Gold, Cheap Banks and the JSE Discount · The Cheapest Stocks in the World (2026): What Value Investing Says About Buying Cheap · global valuation map